Anti-citrullinated protein antibody specificities and pulmonary fibrosis in relation to genetic loci in early rheumatoid arthritis
Autor: | Mikael Brink, Lotta Ljung, Monika Hansson, Johan Rönnelid, Rickard Holmdahl, Karl Skriner, Guy Serre, Lars Klareskog, Solbritt Rantapää-Dahlqvist |
---|---|
Rok vydání: | 2022 |
Předmět: |
Reumatologi och inflammation
pulmonary fibrosis autoantibodies Pulmonary Fibrosis GTPase-Activating Proteins genetic loci Anti-Citrullinated Protein Antibodies ACPA specificities Arthritis Rheumatoid Rheumatology Antibody Specificity Genetic Loci Humans Pharmacology (medical) RA Rheumatology and Autoimmunity Autoantibodies |
Zdroj: | Rheumatology (Oxford, England). 61(12) |
ISSN: | 1462-0332 |
Popis: | Objectives Pulmonary manifestations in RA are common comorbidities, but the underlying mechanisms are largely unknown. The added value of a multiplex of ACPA and genetic risk markers was evaluated for the development of pulmonary fibrosis (PF) in an inception cohort. Methods A total of 1184 patients with early RA were consecutively included and followed prospectively from the index date until death or 31 December 2016. The presence of 21 ACPA fine specificities was analysed using a custom-made microarray chip (Thermo Fisher Scientific, Uppsala, Sweden). Three SNPs, previously found related to PF were evaluated, rs2609255 (FAM13A), rs111521887 (TOLLIP) and rs35705950 (MUC5B). ACPA and genetic data were available for 841 RA patients, of whom 50 developed radiologically defined PF. Results In unadjusted analyses, 11 ACPA specificities were associated with PF development. In multiple variable analyses, six ACPA specificities were associated with increased risk of PF: vimentin (Vim)60–75, fibrinogen (Fib)β62–78 (72), Fibα621–635, Bla26, collagen (C)II359–369 and F4-CIT-R (P Conclusion The development of PF in an inception cohort of RA patients was associated with both presence of certain ACPA and the number of ACPA specificities and risk genes. |
Databáze: | OpenAIRE |
Externí odkaz: |